Joseph K Belanoff - Net Worth and Insider Trading
Joseph K Belanoff Net Worth
The estimated net worth of Joseph K Belanoff is at least $164 Million dollars as of 2024-11-13. Joseph K Belanoff is the CEO of Corcept Therapeutics Inc and owns about 2,831,918 shares of Corcept Therapeutics Inc (CORT) stock worth over $164 Million. Details can be seen in Joseph K Belanoff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph K Belanoff has not made any transactions after 2022-07-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph K Belanoff
Joseph K Belanoff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph K Belanoff owns 1 companies in total, including Corcept Therapeutics Inc (CORT) .
Click here to see the complete history of Joseph K Belanoff’s form 4 insider trades.
Insider Ownership Summary of Joseph K Belanoff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2022-07-07 | director & CHIEF EXECUTIVE OFFICER |
Joseph K Belanoff Latest Holdings Summary
Joseph K Belanoff currently owns a total of 1 stock. Joseph K Belanoff owns 2,831,918 shares of Corcept Therapeutics Inc (CORT) as of July 7, 2022, with a value of $164 Million.
Latest Holdings of Joseph K Belanoff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2022-07-07 | 2,831,918 | 57.79 | 163,656,541 |
Holding Weightings of Joseph K Belanoff
Joseph K Belanoff Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph K Belanoff has made a total of 1 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Corcept Therapeutics Inc is the sale of 335,019 shares on July 7, 2022, which brought Joseph K Belanoff around $9 Million.
Insider Trading History of Joseph K Belanoff
- 1
Joseph K Belanoff Trading Performance
Joseph K Belanoff Ownership Network
Ownership Network List of Joseph K Belanoff
Ownership Network Relation of Joseph K Belanoff
Joseph K Belanoff Owned Company Details
What does Corcept Therapeutics Inc do?
Who are the key executives at Corcept Therapeutics Inc?
Joseph K Belanoff is the director & CHIEF EXECUTIVE OFFICER of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include Chief Development Officer William Guyer , CHIEF FINANCIAL OFFICER Gary Charles Robb , and Chief Accounting Officer Joseph Douglas Lyon .
Corcept Therapeutics Inc (CORT) Insider Trades Summary
Over the past 18 months, Joseph K Belanoff made no insider transaction in Corcept Therapeutics Inc (CORT). Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 70,000 shares made by Joseph Douglas Lyon , a net sale of 28,750 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .
In summary, during the past 3 months, insiders sold 44,101 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 44,101 shares. During the past 18 months, 517,899 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 517,899 shares.
Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corcept Therapeutics Inc Insider Transactions
Joseph K Belanoff Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph K Belanoff. You might contact Joseph K Belanoff via mailing address: 149 Commonwealth Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
